Skip to content

paris-saclay

The overriding aim of the Servier R&D Institute at Paris-Saclay is to combine the Group’s innovation potential with a powerful ecosystem and a center of scientific excellence. In choosing to integrate Paris-Saclay, Servier is also helping to drive momentum in the local economy and boosting the profile of French research.

2023

opening in 2023

45,000sqm

a building spanning

1,500

employees, capacity.

110

able to accommodate up to 110 people at the start-up incubator

1,850sqm

a surface for the start-up incubator

Video of the presentation of the R&D Institute Paris Saclay
00:00 / 00:00

Boosting momentum in partnerships

Having established a presence in one of the most dynamic innovation communities in the world, Servier is taking advantage of a unique opportunity to establish new partnerships and increase synergies with institutional and private sector research bodies.

Our teams at Servier operate within a high-level community and the Group is in contact with a number of local institutions, such as CNRS, CEA, Paris-Saclay University and the École Polytechnique graduate school. It is also involved in organizing events such as SPRING Saclay, TEDxSaclay, and the Symposium de l’Université Paris-Saclay.

Spotlight on the Paris-Saclay Cluster, a unique research hub

Ranked as one of the eight clusters for innovation worldwide, along with Silicon Valley, Beijing, Boston and Silicon Wadi in Israel, Paris-Saclay has top-tier international influence. The site is home to key names in research as well as international companies, start-ups and renowned universities such as Paris-Saclay University, the first French university included in the Shanghai ranking, where it broke into the Top 15.

Did you know?

Paris-Saclay represents 15% of French research (in terms of the number of researchers) and 40% of employment in public and private research in the Greater Paris region.

Ultimately, it will represent 25% of French research.

Spartners by Servier & BioLabs, the incubator for start-ups driving therapeutic innovation

Logo Spartners by Servier & BioLabs

The start-up incubator, Spartners by Servier & BioLabs, hosted at the Servier Research and Development Institute is unique in France. This new synergy between the momentum of young, future-facing companies and Servier’s pharmaceutical knowledge will therefore create unique conditions that will accelerate therapeutic research.

Spartners by Servier & BioLabs, the 1,850 sqm incubator, features laboratories with state-of-the-art equipment alongside specially designed offices to facilitate discussion, as well as reception and catering areas. BioLabs, the premier US-based network of incubators open to high-potential start-ups, oversees the day-to-day management at the facility, supply equipment, provide services, offer practical support, and organize events and programs specially designed for start-ups operating in the life sciences industry.

Spartners by Servier & BioLabs was designed with capacity for over 100 scientists —i.e., around 15 start-ups, which turnover every two years on average.

An environmentally friendly, sustainable building

In line with its Corporate Social Responsibility (CSR) strategy, Servier decided to set a new benchmark with the Paris-Saclay R&D Institute when it comes to sustainability. The Group is aiming to obtain the BiodiverCity® label, alongside WELL Building Standard® and HQE certification, by developing a building that is both environmentally friendly and supports biodiversity.

  • The international BiodiverCity® label attests a certain level of excellence when it comes to ecology and sustainable construction.
  • The WELL Building Standard® certification focuses on people’s health and well-being.
  • The High Environmental Quality (HQE) certification recognizes buildings with the best environmental and energy performance right from their design.

Did you know?

5,000sqm

of on-the-ground green spaces

9,000sqm

of green roofs

100sqm

of community gardens

Read more about the R&D
Institute in Paris-Saclay

Photo credit: ©Martin Argyroglo